Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

National patterns and predictors of liver biopsy use for management of hepatitis C.

Groessl EJ, Liu L, Ho SB, Kanwal F, Gifford AL, Asch SM.

J Hepatol. 2012 Aug;57(2):252-9. doi: 10.1016/j.jhep.2012.03.021. Epub 2012 Apr 17.

PMID:
22521358
2.

Outcomes of a Hepatitis C screening program at a large urban VA medical center.

Groom H, Dieperink E, Nelson DB, Garrard J, Johnson JR, Ewing SL, Stockley H, Durfee J, Jonk Y, Willenbring ML, Ho SB.

J Clin Gastroenterol. 2008 Jan;42(1):97-106.

PMID:
18097298
3.

Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.

Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.

Am J Gastroenterol. 1997 Sep;92(9):1453-7.

PMID:
9317061
4.

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Seeff LB, Hoofnagle JH.

Clin Liver Dis. 2003 Feb;7(1):261-87. Review.

PMID:
12691470
5.

A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.

Okanoue T, Makiyama A, Nakayama M, Sumida Y, Mitsuyoshi H, Nakajima T, Yasui K, Minami M, Itoh Y.

J Hepatol. 2005 Oct;43(4):599-605.

PMID:
16024129
6.

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.

Posthouwer D, Mauser-Bunschoten EP, Fischer K, VAN Erpecum KJ, DE Knegt RJ.

J Thromb Haemost. 2007 Jan;5(1):25-30.

7.

Comparison of characteristics of treated and non-treated patients with Hepatitis C infection.

Hare CB, Morris JA, Chu A, Gotz V, Loveland JJ, Hodes D, Klaskala W.

Pharmacoepidemiol Drug Saf. 2006 Feb;15(2):71-6.

PMID:
16136612
8.

The performance of process measures in hepatitis C.

Kanwal F, Hoang T, Kramer J, Chrusciel T, El-Serag H, Dominitz JA, Asch SM.

Am J Gastroenterol. 2012 Oct;107(10):1512-21. doi: 10.1038/ajg.2012.201. Epub 2012 Jul 10.

PMID:
22777337
9.

Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: modifications in three consecutive large surveys between 2004 and 2009.

Cacoub P, Halfon P, Rosenthal E, Bailly F, Sadr FB, Benhamou Y, Chevaliez S, Pawlotsky JM, Piroth L, Yazdanpanah Y, Pol S.

J Hepatol. 2010 Aug;53(2):230-7. doi: 10.1016/j.jhep.2010.03.009. Epub 2010 Apr 27.

PMID:
20493575
10.

Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.

Nieminen U, Arkkila PE, Kärkkäinen P, Färkkilä MA.

Liver Int. 2009 Feb;29(2):153-8. doi: 10.1111/j.1478-3231.2008.01779.x. Epub 2008 May 14.

PMID:
18482270
11.

Non-invasive assessment of inflammatory activity and fibrosis (grade and stage) in chronic hepatitis C infection.

Verbaan H, Bondeson L, Eriksson S.

Scand J Gastroenterol. 1997 May;32(5):494-9.

PMID:
9175214
12.

Advances in the treatment of hepatitis C.

Lawrence SP.

Adv Intern Med. 2000;45:65-105. Review.

PMID:
10635046
13.

Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.

Rostaing L, Izopet J, Cisterne JM, Arnaud C, Duffaut M, Rumeau JL, Puel J, Durand D.

Transplantation. 1998 Apr 15;65(7):930-6.

PMID:
9565097
14.

Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.

Petrovic LM, Villamil FG, Vierling JM, Makowka L, Geller SA.

Liver Transpl Surg. 1997 Jul;3(4):398-406.

15.

Long-term outcome of hepatitis C infection after liver transplantation.

Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R.

N Engl J Med. 1996 Mar 28;334(13):815-20.

17.

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis.

Soto B, Sánchez-Quijano A, Rodrigo L, del Olmo JA, García-Bengoechea M, Hernández-Quero J, Rey C, Abad MA, Rodríguez M, Sales Gilabert M, González F, Mirón P, Caruz A, Relimpio F, Torronteras R, Leal M, Lissen E.

J Hepatol. 1997 Jan;26(1):1-5.

PMID:
9147999
18.
19.

Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.

Antúnez I, Aponte N, Fernández-Carbia A, Rodríguez-Perez F, Toro DH.

P R Health Sci J. 2004 Jun;23(2 Suppl):57-60.

PMID:
16929588
20.

Supplemental Content

Support Center